Yes. I agree. But I think most of the expenses was start up and roll out of new med products. I listened to the confidante call. Seemed like this 1/4 is in line with last. CEO stated we are having a very good quarter.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.